Lori Moore

Aerie Pharmaceuticals (United States) — United States

Medicine · Health Sciences

3h-index290citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(3), Protein Kinase Regulation and GTPase Signaling(2), Glaucoma and retinal disorders(2), Corneal surgery and disorders(1), Adenosine and Purinergic Signaling(1)

Publications5 total

Ocular Tissue Distribution and Duration of Release of AR-13503 Following Administration of AR-13503 Sustained Release Intravitreal Implant in Rabbits and Miniature Swine
Investigative Ophthalmology & Visual Science·2019· 4 citedOpen Access
AR-13503 Enhances the Efficacy of Aflibercept in a Mouse Model of Proliferative Diabetic Retinopathy
Investigative Ophthalmology & Visual Science·2018· 1 citedOpen Access
Therapeutic Potential of Sustained Delivery of AR-13154(S) in an Animal Model of Proliferative Diabetic Retinopathy
Investigative Ophthalmology & Visual Science·2017Open Access
Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Journal of Ocular Pharmacology and Therapeutics·2017· 181 citedOpen Access
Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Bioorganic & Medicinal Chemistry Letters·2016· 104 citedOpen Access

Frequent Co-authors

Cheng‐Wen Lin(5), Casey Kopczynski(4), Jindong Ding(3), Kevin Carbajal(3), Meredith Weksler(3), Bryan W. Sherman(2), Carmen Laethem(2), Mitchell A. deLong(2), Da‐Wen Lu(1), Padmanabhan P. Pattabiraman(1), Ponugoti Vasantha Rao(1), Jill M. Sturdivant(1), Susan M. Royalty(1), Jeffrey D. Yingling(1), Geoffrey R. Heintzelman(1), Karen M. Crews(1), Eric J. Carlson(1)